Iovance Biotherapeutics Inc (FRA:2LB)
€ 3.655 -0.28 (-7.23%) Market Cap: 1.65 Bil Enterprise Value: 1.42 Bil PE Ratio: 0 PB Ratio: 2.55 GF Score: 44/100

Iovance Biotherapeutics Inc Annual Shareholders Meeting Transcript

Jun 10, 2026 / 03:00 PM GMT
Release Date Price: €3.33 (-3.34%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

IOVA.OQ - Iovance Biotherapeutics Inc
Iovance Biotherapeutics Inc Annual Shareholders Meeting
Jun 10, 2026 / 03:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning. Will the meeting please come to order? My name is Ian Dukes and I'm the Chairman of the Board of Directors of IAvance Biotherapeutics Incorporated. I'm pleased to welcome all of you to this annual meeting of the stockholders of IAvance Biotherapeutics. This meeting has been held virtually through a live webcast.

Several of I've answered directors and executive officers are attending today's meeting virtually.

Two of our officers, Colleen Roche, our Chief Financial Officer, and Fred Boit, our Interim Chief Executive Officer and President and General Counsel, are in attendance and available to answer questions.

Also present is Iqbal Shawpuri, a representative of Ernst &
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot